Sitagliptin Tablet Manufacturers In India

Efpia Medicine Pvt. Ltd. is a reputable and ISO–WHO-GMP-certified pharmaceutical company based in India with 20 years of industry experience. We specialize in manufacturing and supplying top-quality Sitagliptin tablets in combination with Metformin, which is available in two variants under the brand names Tesaril M 50/500 and Tesaril M 50/1000.

These variants are scientifically formulated to ensure prolonged glucose control, minimal side effects, and improved patient adherence. Focusing on efficacy and tolerability, Tesaril M supports better cardiometabolic health and helps reduce long-term diabetes complications.

At Efpia, we are committed to innovative formulations, stringent quality controls, and ethical manufacturing practices that meet national and international regulatory standards. As a leading Sitagliptin tablet manufacturers in India, we cater to hospitals, clinics, and pharmaceutical distributors through PCD franchise and Third-party manufacturing services.

Sitagliptin: A Modern Approach for Diabetes Management

Diabetes is a chronic metabolic disorder that elevates the blood sugar level. It is primarily of two types—Type 1 and Type 2—with Type 2 diabetes being more common, particularly among adults. Sitagliptin is a modern anti-diabetic medication classified under DPP-4 (Dipeptidyl Peptidase-4) inhibitors. Combined with Metformin, a biguanide class of medicine, it helps reduce hepatic glucose production and improves insulin sensitivity in peripheral tissues. The combination improves glycemic control in patients with Type 2 diabetes by:

• Increasing insulin release in response to meals
• Reducing the amount of glucose produced by the liver
• Enhancing the action of incretin hormones, which play a vital role in blood sugar regulation

Evidence-Based Efficacy

Clinical trials and research data have shown that Sitagliptin and metformin hydrochloride tablets:

• Significantly lowers HbA1c levels (glycated hemoglobin) in Type 2 diabetic patients
• Has a low risk of hypoglycemia
• It is weight-neutral, making it suitable for obese or overweight diabetic individuals
• Offers effective glucose control when used as monotherapy or in combination with other antidiabetics (e.g., Metformin)

Why Should You Rely on Efpia Medicine Pvt. Ltd. as Your Go-To Sitagliptin Supplier?

• WHO-GMP & ISO-Certified Manufacturing Facilities
• Stringent Quality Control & International-Standard Testing
• Premium-Quality Raw Materials
• Cost-Effective & Timely Delivery pan India
• Customizable Packaging & Formulations Available

Our commitment to quality, safety, and affordability makes us a preferred partner for sitagliptin phosphate manufacturers in India.

PCD Pharma Franchise & Third-Party Manufacturing Services

At Efpia, we are not just manufacturers but growth enablers for your business. We offer:

• PCD Pharma Franchise Opportunities: Start your brand with our support, product portfolio, and marketing inputs.
• Third-Party Manufacturing: Outsource your Sitagliptin or other diabetic range manufacturing to us with complete transparency, documentation, and scalability.

A Genuine Sitagliptin Supplier for Advanced Diabetes Care

With a mission to redefine diabetes management, Efpia delivers an advanced approach to Diabetes with Consistent Control and Prolonged Release through its well-researched, patient-compliant formulations. Our Sitagliptin range is manufactured under expert supervision and adheres to global safety norms.

Collaborate with Efpia Medicine Pvt. Ltd. Today!

For superior-quality Sitagliptin tablets and reliable pharma partnerships across India, connect with Efpia Medicine Pvt. Ltd., your trusted sitagliptin manufacturer in India.

Frequently Asked Questions (FAQs)

1. What is the indication for Sitagliptin or Sitagliptin + Metformin tablets?

These tablets are indicated for:

• Type 2 Diabetes Mellitus
• Cardiometabolic risk management in diabetic patients with associated risk factors like hypertension, dyslipidemia, and obesity.

2. How often should Sitagliptin or Sitagliptin + Metformin tablets be taken?

Typically, once or twice daily, depending on the dosage form (immediate or prolonged release) and physician’s recommendation. Following your doctor’s advice for optimal blood sugar control is crucial.

3. Are there any side effects associated with these tablets?

Sitagliptin and Metformin are generally well-tolerated. Common side effects, if any, may include:

• Mild gastrointestinal discomfort (with Metformin)
• Headache or upper respiratory symptoms (with Sitagliptin)
• The prolonged-release version helps reduce gastric issues significantly.

4. Why choose Efpia Medicine Pvt. Ltd. as a Sitagliptin tablet manufacturer in India?

• WHO-GMP and ISO-certified facilities
• Advanced manufacturing technology
• High-quality raw materials
• Timely delivery with consistent product quality
• Proven track record in diabetes care manufacturing

5. Can I get Sitagliptin tablets through third-party manufacturing from Efpia?

Absolutely. Efpia offers third-party manufacturing services with full regulatory support, competitive pricing, customized branding, and timely supply to help you scale your pharmaceutical business.